Atlas Trials

Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment

Clinical trial NCT06788626 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06788626
Sponsor
Wei Hu
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Ischemic StrokeLarge Vessel OcclusionNeuroprotective DrugsEndovascular Treatment
Start date
2025-02-01
Primary completion
2028-02-01
Enrollment
390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.